Search
SOLACI Congress
Coronary diseaseDay 2

SOLACI-SOCIME 2022 | Treatment Consideration in Women: Results from the RECOVER III Study – By Dr. Alexandra Lansky

solaci
solaci
128
0

Disfrute esta conferencia magistral brindada por la Dra. Alexandra Lansky durante el Congreso SOLACI-SOCIME 2022 realizado en Expo Santa Fé, CDMX los días 4, 5 y 6 de agosto de 2022.

Tema: Treatment Consideration in Women: Results from the RECOVER III Study

Suscríbase a nuestro newsletter semanal

Reciba resúmenes con los últimos artículos científicos

Previous article
The Best Moments of SOLACI-SOCIME 2022
Next article
SOLACI-SOCIME 2022 | The future of the innovation in cardiovascular interventions – Dr. Chaim Lotan
solaci
solaci

More articles by this author

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

Dr. Andrés Rodríguez - 0
In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

FRANCE TAVI Registry: Coronary Adverse Events After TAVI

Dr. Andrés Rodríguez - 0
Between 30% and 70% of patients undergoing transcatheter aortic valve implantation (TAVI) have coronary artery disease (CAD). However, the prognostic impact of CAD in...

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

Dr. Andrés Rodríguez - 0
The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Dr. Omar Tupayachi - 0
Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Chronic Coronary Syndromes

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several...
Dr. Andrés Rodríguez -
SOLACI Sessionsspot_img

Recent Articles

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Dr. Andrés Rodríguez - 0
Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

Dr. Andrés Rodríguez - 0
In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

FRANCE TAVI Registry: Coronary Adverse Events After TAVI

Dr. Andrés Rodríguez - 0
Between 30% and 70% of patients undergoing transcatheter aortic valve implantation (TAVI) have coronary artery disease (CAD). However, the prognostic impact of CAD in...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Dr. Andrés Rodríguez - 0
Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

Dr. Andrés Rodríguez - 0
In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

FRANCE TAVI Registry: Coronary Adverse Events After TAVI

Dr. Andrés Rodríguez - 0
Between 30% and 70% of patients undergoing transcatheter aortic valve implantation (TAVI) have coronary artery disease (CAD). However, the prognostic impact of CAD in...

Institutional News

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

Uruguay Sessions 2025 | Young Interventional Cardiologists Contest

solaci - 0
Call for Case Submission LI SOLACI Regional Sessions – 16° Southern Cone  It is with great pleasure that we hereby invite all young Latin American cardiologists...

Watch Angioplasty Techniques for Bifurcations Again From a Completely Different Perspective.

solaci - 0
You can now watch on our YouTube channel the event we held in collaboration with Medtronic, titled: "Visualizations of Different PCI Techniques for Bifurcations...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy